Recent news headlines have spotlighted how unethical and irresponsible behavior on the part of pharma companies and their agencies can breach public trust and negatively impact patient lives. As a respect-centered organization, trust is one of our five core values. It’s imperative to partner with those who match your values – or be prepared to walk away. V2V President Dan Rehal shares a story about trust in this short video.
Trust is a Two-Way Street
ABOUT THE AUTHOR
Daniel J. Rehal
As President of Vision2Voice, Daniel thoroughly understands the pharmaceutical industry from the ground floor up. By ascending the ranks at Merck to his global responsibilities at Takeda, Dan has significant experience in both marketing and sales roles supporting a multitude of pharmaceutical brands as an award-winning Sales Representative, Training Manager, District Manager, Senior Product Manager, and Marketing Director.
Recent Posts
Will Your Launch Strategy Succeed or Fail?
The Challenge: A Faster, More Complex Launch Environment In today’s pharmaceutical market, strong science is the foundation, but it doesn’t always guarantee a successful launch....
Read More
Industry Insights – June 2026
From evolving China deal dynamics and prolonged job searches to the growing push for AI-driven drug repurposing, explore how shifts in BioPharma are redefining innovation,...
Read More
Industry Insights – May 2026
Biosimilars are gaining U.S. momentum even as patent thickets keep triggering legal fights, small biotechs are feeling the pressure of the FDA’s faster-moving approval environment,...
Read More